摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(4-氯苯亚甲基)环丙胺 | 1013624-47-9

中文名称
N-(4-氯苯亚甲基)环丙胺
中文别名
——
英文名称
N-(4-chlorobenzylidene)cyclopropanamine
英文别名
4-chlorobenzylidene cyclopropylamine;1-(4-chlorophenyl)-N-cyclopropylmethanimine
N-(4-氯苯亚甲基)环丙胺化学式
CAS
1013624-47-9
化学式
C10H10ClN
mdl
——
分子量
179.649
InChiKey
MPVVBSYVVJWMAD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    12.4
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    N-(4-氯苯亚甲基)环丙胺 在 sodium tetrahydroborate 、 sodium tungstate 、 双氧水 作用下, 以 甲醇 为溶剂, 生成 1-(4-chlorophenyl)-N-cyclopropylmethanimine oxide
    参考文献:
    名称:
    Synthesis of C-Aryl-N-cyclopropylnitrones
    摘要:
    Synthesis of C-aryl-N-cyclopropylnitrones is described. Preparations were performed either by condensation of the appropriate aldehyde with N-cyclopropyl-hydroxylamine, or oxidation of N-substituted N-cyclopropylamines with sodium tungstate/hydrogen peroxide.
    DOI:
    10.1081/scc-120024001
  • 作为产物:
    描述:
    4-氯苯甲醇2-碘酰基苯甲酸 作用下, 以 甲醇乙腈 为溶剂, 反应 1.0h, 生成 N-(4-氯苯亚甲基)环丙胺
    参考文献:
    名称:
    Ugi Four-Component Reaction of Alcohols: Stoichiometric and Catalytic Oxidation/MCR Sequences
    摘要:
    A new, simple, and efficient procedure for the one-pot Ugi four-component reaction of alcohols instead of aldehydes is described. Using a stoichiometric amount of IBX or only 1-2% of sodium 2-iodobenzenesulfonate in the presence of Oxone, a wide range of primary alcohols were oxidized to the aldehyde that were directly engaged in the Ugi four-component reaction to afford alpha-acetamidoamides in good to excellent yields.
    DOI:
    10.1021/ol401181a
点击查看最新优质反应信息

文献信息

  • T-type calcium channel blockers: spiro-piperidine azetidines and azetidinones—optimization, design and synthesis
    作者:Elizabeth M. Smith、Steve Sorota、Hyunjin M. Kim、Brian A. McKittrick、Terry L. Nechuta、Chad Bennett、Chad Knutson、Duane A. Burnett、Jane Kieselgof、Zheng Tan、Diane Rindgen、Terry Bridal、Xiaoping Zhou、Yu-Ping Jia、Zoe Dong、Debbie Mullins、Xiaoping Zhang、Tony Priestley、Craig C. Correll、Deen Tulshian、Michael Czarniecki、William J. Greenlee
    DOI:10.1016/j.bmcl.2010.06.012
    日期:2010.8
    A series of spiro-azetidines and azetidinones has been evaluated as novel blockers of the T-type calcium channel (CaV3.2) which is a new therapeutic target for the potential treatment of both inflammatory and neuropathic pain. Confirmation and optimization of the potency, selectivity and DMPK properties of leads will be described.
    已经评估了一系列螺氮杂环丁烷和氮杂环丁酮作为T型通道(Ca V 3.2)的新型阻滞剂,它是潜在治疗炎性和神经性疼痛的新治疗靶标。将描述和验证潜在性,选择性和DMPK特性的优化。
  • Pseudo-Seven-Component Double Azido-Ugi Reaction: an Efficient Synthesis of Bistetrazole Derivatives
    作者:Irina V. Kutovaya、Danil P. Zarezin、Olga I. Shmatova、Valentine G. Nenajdenko
    DOI:10.1002/ejoc.201900662
    日期:2019.6.30
    Pseudo‐seven‐component double azido‐Ugi reactions were investigated. Compounds bearing two 1,5‐disubstituted tetrazole rings in the structure were obtained by the proposed approach. Bis‐NH‐tetrazoles were synthesized by means of catalytic debenzylation of bis‐N‐benzyltetrazoles.
    研究了伪七成分双叠氮基-Ugi反应。通过提出的方法获得了在结构中带有两个1,5-二取代的四唑环的化合物。通过双-N-苄基四唑的催化脱苄基作用合成了双-NH-四唑
  • Synthesis and spectral studies on Cd(II) dithiocarbamate complexes and their use as precursors for CdS nanoparticles
    作者:Ethiraj Sathiyaraj、Krishnaraj Padmavathy、Chandran Udhaya Kumar、Kannan Gokula Krishnan、Chennan Ramalingan
    DOI:10.1016/j.molstruc.2017.06.080
    日期:2017.11
    experimental results. The complexes 1 and 2 have been used as single source precursors for the synthesis of ethyleneglycol capped CdS 1 and CdS 2 nanoparticles, respectively. CdS 1 and CdS 2 nanoparticles have been synthesized by solvothermal method. PXRD, SEM, Elemental colour mapping, EDAX, TEM and UV–Vis spectroscopy have been used to characterize the as-prepared CdS nanoparticles. The X-ray diffraction
    摘要 双(N-环丙基-N-4-苄基二氨基甲酸-S,S ')(II) ( 1 ) 和 (2,2'-联吡啶) 双( N-环丙基-N-4-苄基二氨基甲酸- S,S ' ) (II) ( 2 ) 已通过 FT-IR、 1 HNMR 和 13 C NMR 分析进行合成和表征。对于复合物 2 ,已使用 DFT/B3LYP 方法和 LANL 2DZ 基本集执行单晶 X 射线衍射分析和计算研究(优化几何、HOMO-LUMO 和 MEP)。优化后的键长和键角与实验结果吻合良好。复合物 1 和 2 已分别用作合成乙二醇封端的 CdS 1 和 CdS 2 纳米粒子的单一来源前体。CdS 1 和CdS 2 纳米颗粒已通过溶剂热法合成。PXRD、SEM、元素颜色映射、EDAX、TEM 和 UV-Vis 光谱已被用于表征所制备的 CdS 纳米粒子。X 射线衍射图证实了它们的六边形结构。
  • Synthesis and spectroscopic characterization of Ni(II) complexes involving functionalised dithiocarbamates and triphenylphosphine: Anagostic interaction in (N-cyclopropyl-N-(4-fluorobenzyl)dithiocarbamato-S,S′) (thiocyanato-N)(triphenylphosphine)nickel(II)
    作者:E. Sathiyaraj、T. Srinivasan、S. Thirumaran、D. Velmurugan
    DOI:10.1016/j.molstruc.2015.08.053
    日期:2015.12
    presence of the π-accepting triphenylphosphine. Electronic spectral studies indicated square planar geometry around the nickel(II) central atom for all the complexes. Single crystal X-ray structural analysis of 11 confirms that the coordination geometry about the Ni is distorted square planar. The C–H…F interactions lead to a polymeric structure and a rare intramolecular anagostic interaction [M…H = 2
    摘要 十二种新的 (II) 配合物,即 [Ni(S2CNRR')2](1-6) 和 [Ni(S2CNRR')(NCS)(PPh3)](7-12) [其中 R = 环丙基 (cPr); R' = 2HO–C6H4CH2– (1,7)、3HO– – – (2,8)、4HO– – – (3,9)、4CH3O– – – (4,10) , 4F– – – (5,11), 4Cl– – – (6,12)] 已通过元素分析、IR、UV–Vis 和 NMR(1H 和 13C)光谱制备和表征。对(N-环丙基-N-(4-苄基)二氨基甲酸根-S,S')(硫氰酸根合-N)-(三苯基膦(II)进行单晶X射线结构分析。与均配配合物 1-6 相比,vC-N 硫脲的波数增加和杂配配合物 7-12 的化学位移值降低是由于电子密度从二氨基甲酸酯部分向属中心的中间漂移,增加碳氮双键特性。C-N
  • AZETIDINE DERIVATIVES USEFUL IN TREATING PAIN, DIABETES AND DISORDERS OF LIPID METABOLISM
    申请人:McKittrick A. Brian
    公开号:US20080089858A1
    公开(公告)日:2008-04-17
    Disclosed are compounds of the formula: and compounds of the formula: wherein R 1 , R 2 , R 3 , R 4 , R 5 , u and v are as defined herein. Also disclosed are methods of treating pain (e.g., inflammatory pain, chronic pain, and neuropathic pain), methods of treating diabetes, and methods of inhibiting the absorption of cholesterol using compounds of formula I or IIA.
    本发明涉及以下式的化合物:以及以下式的化合物:其中R1,R2,R3,R4,R5,u和v如本文所定义。本发明还涉及使用I或IIA式化合物治疗疼痛(例如,炎性疼痛,慢性疼痛和神经病理性疼痛)的方法,治疗糖尿病的方法以及抑制胆固醇吸收的方法。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫